The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Tumors and inflammatory infiltrates: Friends or foes?
Abstract
The recognition of a role for inflammation in the natural history of a tumor has a long record, stretching from the mid-19th century. From the times of Virkow, who postulated that cancer originates from inflamed tissues, to Metchnikoff and many others, this field has continued to excite (and divide) the scientific community. The question as to whether the inflammatory infiltrate helps or hinders tumors is still open. In a sense, modern molecular biology has, if anything, worsened this dualism, and the literature on this issue shows a plethora of conflicting reports. We would like to provide another contribution to this topic, which was the subject of a recent brilliant review (Balkwill F and Mantovani A. Lancet 2001; 357: 539-45), by focussing more specifically to the relation between inflammation and tumor invasion and how this could drive rational therapeutic approaches.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TAMs have a dual role in neoplasms — although they may kill neoplastic cells following activation by IL-2, interferon and IL-12 (refs 15, 16), TAMs produce a number of potent angiogenic and lymphangiogenic growth factors, cytokines and proteases, all of which are mediators that potentiate neoplastic progression17.”
From Inflammation and cancer (2002) · cites this paper as [15]
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 1×
“ATP synthase-inhibitors, such as Piceatannol [67] and Resveratrol [68] are effective inhibitors of tumor growth.”
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,232
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909.909_909_928 · Cited by 2,126
Ulcerative Colitis and Colorectal Cancer
Ekbom, A., Helmick, C. G., Zack, M. M., & Adami, H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,794
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,547
Flagged first, then by citations
1 of the 125 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Rollins BJ. Chemokines. Blood 1997; 90: 909–28. · DOI
- Richard D, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000; 275: 26765–71. · DOI
- Johnson W, Anderson K, Lazovich D et al. Association of aspirin and other NSAID use with incidence of postmenopausal breast cancer. In Proceedings of AACR, New Orleans 2001; 763.
- Cao Y, Prescott S. Fatty acid CoA-ligase 4 and cyclooxygenase 2 promote carcinogenesis by lowering the intracellular level of free arachidonic acid. In Proceedings of AACR, New Orleans 2001; 591.
Cited by
Sorted by citations
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,413
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,242
Inflammation, a Key Event in Cancer Development
Lu, H., Ouyang, W., & Huang, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0261 · Cited by 1,049
Surface exposure of phosphatidylserine in pathological cells
Zwaal, R. F. A., Comfurius, P., & Bevers, E. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4527-3 · Cited by 753
Nanooncology: The future of cancer diagnosis and therapy
Thakor, A. S., & Gambhir, S. S. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21199 · Cited by 602
Roca, H., Varsos, Z. S., Sud, S., Craig, M. J., Chi, Y., & Pienta, K. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042671 · Cited by 587
Innate immunity and inflammation in ageing: a key for understanding age-related diseases
Licastro, F., Candore, G., Lio, D., Porcellini, E., Colonna-Romano, G., Franceschi, C., & Caruso, C. (2005) · Immunity & Ageing · doi:10.1186/1742-4933-2-8 · Cited by 453
Role of macrophages in tumour progression
Siveen, K. S., & Kuttan, G. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.02.011 · Cited by 355
Ben‐Baruch, A. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.006 · Cited by 336
Chemokines, chemokine receptors, and cancer metastasis
Kakinuma, T., & Hwang, S. T. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105633 · Cited by 340
Monocyte/macrophage infiltration in tumors: modulators of angiogenesis
Dirkx, A. E. M., Egbrink, M. G. A. O., Wagstaff, J., & Griffioen, A. W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905495 · Cited by 330
Inflammatory cell infiltration of tumors: Jekyll or Hyde
Talmadge, J. E., Donkor, M. K., & Scholar, E. M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9072-0 · Cited by 312
Dual role of macrophages in tumor growth and angiogenesis
Lamagna, C., Aurrand‐Lions, M., & Imhof, B. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105656 · Cited by 318
The bone microenvironment in metastasis; what is special about bone?
Bussard, K. M., Gay, C. V., & Mastro, A. M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9109-4 · Cited by 307
Gazzaniga, S., Bravo, A., Guglielmotti, A., van Rooijen, N., Maschi, F., Vecchi, A., Mantovani, A., Mordoh, J., & Wainstok, R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700827 · Cited by 302
Portrait of inflammatory response to ionizing radiation treatment
Maggio, F. M. D., Minafra, L., Forte, G. I., Cammarata, F. P., Lio, D., Messa, C., Gilardi, M. C., & Bravatà, V. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0058-3 · Cited by 293
The multifaceted roles of chemokines in malignancy
Ben‐Baruch, A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9003-5 · Cited by 254
Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer
Schimanski, C. C., Schwald, S., Simiantonaki, N., Jayasinghe, C., Gönner, U., Wilsberg, V., Junginger, T., Berger, M. R., Galle, P. R., & Moehler, M. H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1195 · Cited by 262
Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
Yang, S., & Gao, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.004 · Cited by 256
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions
Noonan, D. M., Barbaro, A. D. L., Vannini, N., Mortara, L., & Albini, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9108-5 · Cited by 255
Self-citationBalkwill, F. R. (2002) · Seminars in Immunology · doi:10.1016/s1044-5323(02)00127-6 · Cited by 238
Küchler, A. M., Pollheimer, J., Balogh, J., Sponheim, J., Manley, L., Sørensen, D. R., Angelis, P. M. D., Scott, H., & Haraldsen, G. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080014 · Cited by 221
AllergoOncology: the role of IgE‐mediated allergy in cancer
Jensen‐Jarolim, E., Achatz, G., Turner, M. C., Karagiannis, S. N., Legrand, F., Capron, M., Penichet, M. L., Rodríguez, J. A., Siccardi, A. G., Vangelista, L., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01768.x · Cited by 222
Aging, Longevity, Inflammation, and Cancer
Caruso, C., Lio, D., Cavallone, L., & Franceschi, C. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1322.001 · Cited by 218
Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression
Rhee, K., Lee, J. E., & Eom, Y. W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226215 · Cited by 221
Extracellular ATP and adenosine: The Yin and Yang in immune responses?
Faas, M. M., Sáez, T., & de Vos, P. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.01.002 · Cited by 216
Monti, P., Leone, B. E., Marchesi, F., Balzano, G., Zerbi, A., Scaltrini, F., Pasquali, C., Calori, G., Pessi, F., Sperti, C., et al. (2003) · PubMed · Cited by 208
Cassetta, L., & Kitamura, T. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00038 · Cited by 200
“Macrophages are also potentially able to mount a robust anti-tumoral response as they can directly kill cancer cells if properly activated and support the adaptive immune response by presenting tumor antigens and by producing chemokines and cytokines that recruit and activate cytotoxic CD8 T cells and NK cells (Giffor…”
BackgroundEffect of high-dose intravenous vitamin C on inflammation in cancer patients
Mikirova, N. A., Casciari, J. J., Rogers, A. S., & Taylor, P. R. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-189 · Cited by 196
Immune Suppression in Head and Neck Cancers: A Review
Duray, A., Demoulin, S., Hubert, P., Delvenne, P., & Saussez, S. (2010) · Journal of Immunology Research · doi:10.1155/2010/701657 · Cited by 182
Multi-action Pt(IV) anticancer agents; do we understand how they work?
Gibson, D. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.11.008 · Cited by 180
Kim, E. Y., Lee, J. W., Yoo, H. M., Park, C. H., & Song, K. Y. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4518-z · Cited by 177
Itakura, E., Huang, R., Wen, D., Paul, E., Wünsch, P. H., & Cochran, A. J. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.5 · Cited by 174
ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma.
Hernán, R., Fasheh, R., Calabrese, C. R., Frank, A. J., Maclean, K. H., Allard, D., Barraclough, R., & Gilbertson, R. J. (2003) · PubMed · Cited by 170
Inflammation in epithelial skin tumours: Old stories and new ideas
Mueller, M. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.014 · Cited by 169
Klemke, M., Weschenfelder, T., Konstandin, M. H., & Samstag, Y. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21029 · Cited by 167
Shurin, M. R., Shurin, G. V., Lokshin, A. E., Yurkovetsky, Z. R., Gutkin, D. W., Chatta, G. S., Zhong, H., Han, B., & Ferris, R. L. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9010-6 · Cited by 166
Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy
Micke, P., & Östman, A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.6.1217 · Cited by 163
Angiogenesis and hypoxia in the kidney
Tanaka, T., & Nangaku, M. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.35 · Cited by 158
The Tumor Microenvironment: The Making of a Paradigm
Witz, I. P. (2009) · Cancer Microenvironment · doi:10.1007/s12307-009-0025-8 · Cited by 160
Building the niche: The role of the S100 proteins in metastatic growth
Lukanidin, E. M., & Sleeman, J. P. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.006 · Cited by 152
del Fresno, C., Otero, K., Gómez-Garcı́a, L., González-León, M. C., Rangel, L. S., Fuentes‐Prior, P., Escoll, P., Baos, R., Caveda, L., García, F., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3032 · Cited by 154
Role of Epigenetics in Inflammation-Associated diseases
Shanmugam, M. K., & Sethi, G. (2013) · Subcellular Biochemistry · doi:10.1007/978-94-007-4525-4_27 · Cited by 141
Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections
Dijsselbloem, N., Berghe, W. V., Naeyer, A. D., & Haegeman, G. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.036 · Cited by 138
RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer
Tarcic, O., Pateras, I. S., Cooks, T., Shema, E., Kanterman, J., Ashkenazi, H., Boocholez, H., Hubert, A., Rotkopf, R., Baniyash, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.020 · Cited by 135
Tumor–Microenvironment Interactions: Dangerous Liaisons
Witz, I. P. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00007-9 · Cited by 137
Association of human papillomavirus infection and inflammation in cervical cancer
Hemmat, N., & Baghi, H. B. (2019) · Pathogens and Disease · doi:10.1093/femspd/ftz048 · Cited by 132
Kuroda, T., Kitadai, Y., Tanaka, S., Yang, X., Mukaida, N., Yoshihara, M., & Chayama, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0798 · Cited by 128
Revisiting the seed and soil in cancer metastasis
Mendoza, M., & Khanna, C. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.01.015 · Cited by 126
The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment
Bikfalvi, A., & Billottet, C. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00378.2019 · Cited by 116
Tumor-host interactions: the role of inflammation
Bitoux, M. L., & Stamenkovic, I. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0527-3 · Cited by 113
Nanomedicine Strategies to Target Tumor-Associated Macrophages
Binnemars‐Postma, K., Storm, G., & Prakash, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050979 · Cited by 112
Miselis, N. R., Wu, Z. J., van Rooijen, N., & Kane, A. B. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0579 · Cited by 106
Gallagher, P. G., Bao, Y., Prorock, A. J., Zigrino, P., Nischt, R., Politi, V., Mauch, C., Dragulev, B. P., & Fox, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-0415 · Cited by 105
Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis
Cioroianu, A., Stinga, P. I., Sticlaru, L., Cioplea, M. D., Nichita, L., Popp, C. G., & Stăniceanu, F. (2019) · Analytical Cellular Pathology · doi:10.1155/2019/8586354 · Cited by 102
Phipps, K. D., Surette, A. P., O'Connell, P. A., & Waisman, D. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1748 · Cited by 100
Increased primary tumor growth in mice null for β3- or β3/β5-integrins or selectins
Taverna, D., Moher, H., Crowley, D. G., Borsig, L., Varki, A. P., & Hynes, R. O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307289101 · Cited by 100
Reichle, A., Bross, K., VOGT, T. M., Bataille, F., Wild, P. J., Berand, A., Krause, S. W., & Andreesen, R. (2004) · Cancer · doi:10.1002/cncr.20574 · Cited by 99
Chemokine Receptor-Specific Antibodies in Cancer Immunotherapy: Achievements and Challenges
Vela, M., Aris, M., Llorente, M., García‐Sanz, J. A., & Kremer, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00012 · Cited by 101
Inflammation as a Target for Prostate Cancer Chemoprevention: Pathological and Laboratory Rationale
Lucia, M. S., & Torkko, K. C. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000108142.53241.47 · Cited by 95
The Chemokine CXCL8 in Carcinogenesis and Drug Response
Gales, D. N., Clark, C. E., Manne, U., & Samuel, T. (2013) · ISRN Oncology · doi:10.1155/2013/859154 · Cited by 97
Exercise delays allogeneic tumor growth and reduces intratumoral inflammation and vascularization
Zielinski, M. R., Muenchow, M., Wallig, M. A., Horn, P. L., & Woods, J. A. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01210.2003 · Cited by 94
Zhang, J., Patel, L. R., & Pienta, K. J. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385071-3.00003-4 · Cited by 95
Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma
Xia, W.-K., Liu, Z., Shen, D., Lin, Q.-F., Su, J., & Mao, W. D. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0889-2 · Cited by 92
Yang, C., Hsieh, S.-L., Ho, F., & Lin, W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1647 · Cited by 92
Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways
Eismann, E. A., Cash, E. D., & Sephton, S. E. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.12.011 · Cited by 96
The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes
Albini, A., Benelli, R., Noonan, D. M., & Brigati, C. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041822aa · Cited by 92
Self-citationGene Expression Profiling of Liver Cancer Stem Cells by RNA-Sequencing
Ho, D. W., Yang, Z. F., Kang, Y., Lam, C. T., Ng, M. N. P., Yu, W. C., Lau, J., Wan, T. M.-H., Wang, X., Yan, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037159 · Cited by 89
Solar cheilosis: An ominous precursor
Jadotte, Y. T., & Schwartz, R. A. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.09.040 · Cited by 89
Angiogenesis and Cancer Prevention: A Vision
Noonan, D. M., Benelli, R., & Albini, A. (2007) · Springer eBooks · doi:10.1007/978-3-540-37696-5_19 · Cited by 86
Self-citationZhang, X., Zhao, W., Yu, Y., Qi, X., Song, L., Zhang, C., Li, G., & Yang, L. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-01952-2 · Cited by 81
Mikirova, N. A., Casciari, J. J., Riordan, N. H., & Hunninghake, R. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-191 · Cited by 80
Differential infiltration of CD8+and NK cells in lip and oral cavity squamous cell carcinoma
Zancopé, E., Costa, N. L., Junqueira‐Kipnis, A. P., Valadares, M. C., Silva, T. A., Leles, C. R., Mendonça, E. F., & Batista, A. C. (2009) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2009.00792.x · Cited by 79
Li, Y.-W., Qiu, S., Fan, J., Gao, Q., Zhou, J., Xiao, Y., Xu, Y., Wang, X., Sun, J., & Huang, X. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0469-0 · Cited by 72
Immune cell infiltration of primary and metastatic lesions: Mechanisms and clinical impact
Talmadge, J. E. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.002 · Cited by 74
Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives
Bisacchi, D., Benelli, R., Vanzetto, C., Ferrari, N., Tosetti, F., & Albini, A. (2003) · Cancer Detection and Prevention · doi:10.1016/s0361-090x(03)00030-8 · Cited by 69
Self-citationSun, H., Chung, W.-C., Ryu, S.-H., Ju, Z., Tran, H. T., Kim, E. J.-H., Kurie, J. M., & Koo, J. S. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-07-0002 · Cited by 68
Tumour necrosis factor α confers an invasive, transformed phenotype on mammary epithelial cells
Montesano, R., Soulié, P., Eble, J. A., & Carrozzino, F. (2005) · Journal of Cell Science · doi:10.1242/jcs.02467 · Cited by 66
Cui, G., Goll, R., Olsen, T., Steigen, S. E., Husebekk, A., Vonen, B., & Florholmen, J. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0259-y · Cited by 66
Liu, T., Fang, X.-C., Ding, Z., Sun, Z.-G., Sun, L.-M., & Wang, Y.-L. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.08.002 · Cited by 64
Döme, B., Tı́már, J., Ladányi, A., Paku, S., Renyi-Vamos, F., Klepetko, W., Láng, G., Döme, P., Bogos, K., & Tóvári, J. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.06.009 · Cited by 63
Liang, W. P., Kujawski, M., Wu, J., Lu, J., Herrmann, A., Loera, S., Yen, Y., Lee, F., Yu, H., Wen, W. X., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1486 · Cited by 61
The role of inflammation in cancer of the esophagus
O’Sullivan, K. E., Phelan, J. J., Brown, C. O., Lysaght, J., O'Sullivan, J. N., & Reynolds, J. V. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.913478 · Cited by 61
Takahashi, M., Miyazaki, H., Furihata, M., Sakai, H., Konakahara, T., Watanabe, M., & Okada, T. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9281-8 · Cited by 60
Karagiannis, S. N., Josephs, D. H., Karagiannis, P., Gilbert, A. E., Saul, L., Rudman, S. M., Dodev, T. S., Koers, A., Blower, P. J., Corrigan, C. J., et al. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1162-8 · Cited by 60
Dymicka-Piekarska, V., Koper‐Lenkiewicz, O. M., Dorf, J., Kratz, E. M., & Kamińska, J. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02758-7 · Cited by 59
Sheehan, K. M., Gulmann, C., Eichler, G. S., Weinstein, J. N., Barrett, H. L., Kay, E. W., Conroy, R. M., Liotta, L. A., & Petricoin, E. F. (2007) · Oncogene · doi:10.1038/sj.onc.1210647 · Cited by 59
Nakasone, Y., Fujimoto, M., Matsushita, T., Hamaguchi, Y., Huu, D. L., Yanaba, M., Sato, S., Takehara, K., & Hasegawa, M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.005 · Cited by 61
Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids
Sogno, I., Vannini, N., Lorusso, G., Cammarota, R., Noonan, D. M., Generoso, L., Sporn, M. B., & Albini, A. (2008) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-69297-3_19 · Cited by 58
Self-citationA Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs
Carvalho, M. I., Silva-Carvalho, R., Pires, I. C. R., Prada, J., Bianchini, R., Jensen‐Jarolim, E., & QUEIROGA, F. L. (2016) · BioMed Research International · doi:10.1155/2016/4917387 · Cited by 57
Pro-tumor activities of macrophages in the progression of melanoma
Wang, H., Yang, L., Wang, D., Zhang, Q., & Zhang, L. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1312043 · Cited by 58
An oligonucleotide decoy for Stat3 activates the immune response of macrophages to breast cancer
Sun, Z., Yao, Z., Liu, S., Tang, H., & Xiong, Y. (2006) · Immunobiology · doi:10.1016/j.imbio.2005.11.004 · Cited by 57
Neutrophils and Angiogenesis: Potential Initiators of the Angiogenic Cascade
Benelli, R., Albini, A., & Noonan, D. M. (2003) · KARGER eBooks · doi:10.1159/000071560 · Cited by 53
Self-citationChemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
Saxena, S., & Singh, R. K. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09970-6 · Cited by 54
A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer
Srivani, R., & Nagarajan, B. (2003) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2003.13197.x · Cited by 52
Tumor Immuno-Environment in Cancer Progression and Therapy
Kaliński, P., & Talmadge, J. E. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_1 · Cited by 49
Tajaldini, M., Saeedi, M., Amiriani, T., Amiriani, A., Sedighi, S., Zadeh, F. M., Dehghan, M. H., Jahanshahi, M., Zanjan, M. G., Khalili, P., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175087 · Cited by 46
Son, D., Na, Y. R., Hwang, E.-S., & Seok, S. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.508994 · Cited by 44
Metadata
- Authors
- Brigati, C., Noonan, D. M., Albini, A., & Benelli, R.
- Corresponding author
- Brigati, Claudio
- Venue
- Clinical & Experimental Metastasis
- Published
- 2002-05
- Volume
- 19
- Issue
- 3
- Pages
- 247-258
- ISSN
- 0262-0898 (ISSN-L)
- 1573-7276
- OpenAlex
- W1550108534
- Cited by
- 230
- References
- 125
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 3 · 2022: 9 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 10 · 2016: 10 · 2015: 11 · 2014: 6 · 2013: 10 · 2012: 19
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Clinical & Experimental Metastasis (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Funders
- Compagnia di San Paolo
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- tumor inflammation, inflammatory cell infiltration, tumor invasion, tumor microenvironment
- MeSH terms
- Humans, Inflammation, Models, Biological, Neoplasms, Prostaglandin-Endoperoxide Synthases, Transcription Factors, Cytokines, Receptors, Cytoplasmic and Nuclear, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review